Pharsight

Advil Pm patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8883849 GLAXOSMITHKLINE Treatment of sleep disturbances
Jan, 2022

(2 years ago)

US9155718 GLAXOSMITHKLINE Treatment of sleep disturbances
Jan, 2022

(2 years ago)

Advil Pm is owned by Glaxosmithkline.

Advil Pm contains Diphenhydramine Hydrochloride; Ibuprofen.

Advil Pm has a total of 2 drug patents out of which 2 drug patents have expired.

Expired drug patents of Advil Pm are:

  • US8883849
  • US9155718

Advil Pm was authorised for market use on 21 December, 2005.

Advil Pm is available in capsule;oral dosage forms.

Advil Pm can be used as a method of treating a patient suffering from a pain associated sleep disturbance comprising administering a liquid composition formulated inside a soft gel capsule, as claimed, to the patient.

The generics of Advil Pm are possible to be released after 17 January, 2022.

Drugs and Companies using DIPHENHYDRAMINE HYDROCHLORIDE; IBUPROFEN ingredient

Market Authorisation Date: 21 December, 2005

Treatment: A method of treating a patient suffering from a pain associated sleep disturbance comprising administering a liquid composition formulated inside a soft gel capsule, as claimed, to the patient

Dosage: CAPSULE;ORAL

How can I launch a generic of ADVIL PM before it's drug patent expiration?
More Information on Dosage

ADVIL PM family patents

Family Patents
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8263647 GLAXOSMITHKLINE Treatment of sleep disturbances
May, 2022

(1 year, 9 months ago)

Advil Pm is owned by Glaxosmithkline.

Advil Pm contains Diphenhydramine Citrate; Ibuprofen.

Advil Pm has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Advil Pm are:

  • US8263647

Advil Pm was authorised for market use on 21 December, 2005.

Advil Pm is available in tablet;oral dosage forms.

The generics of Advil Pm are possible to be released after 30 May, 2022.

Drugs and Companies using DIPHENHYDRAMINE CITRATE; IBUPROFEN ingredient

Market Authorisation Date: 21 December, 2005

Treatment: NA

Dosage: TABLET;ORAL

How can I launch a generic of ADVIL PM before it's drug patent expiration?
More Information on Dosage

ADVIL PM family patents

Family Patents